Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

52.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

23
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
23
Homologous Recombination02:31

Homologous Recombination

50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPRC6A-Duox1 Axis Regulates the Hair Cycle Through H<sub>2</sub>O<sub>2</sub> Generation.

Tissue engineering and regenerative medicine·2026
Same author

In vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON.

Nature communications·2025
Same author

An innovative approach using CRISPR-ribonucleoprotein packaged in virus-like particles to generate genetically engineered mouse models.

Nature communications·2025
Same author

Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1.

Nature communications·2025
Same author

Comprehensive phenotypic assessment of nonsense mutations in mitochondrial ND5 in mice.

Experimental & molecular medicine·2024
Same author

FGF4 and ascorbic acid enhance the maturation of induced cardiomyocytes by activating JAK2-STAT3 signaling.

Experimental & molecular medicine·2024

Related Experiment Video

Updated: Jul 12, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.3K

Recent Research Trends in Stem Cells Using CRISPR/Cas-Based Genome Editing Methods.

Da Eun Yoon1,2, Hyunji Lee1,3, Kyoungmi Kim1,2

  • 1Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea.

International Journal of Stem Cells
|October 31, 2023
PubMed
Summary
This summary is machine-generated.

CRISPR gene editing technology enables precise DNA alterations in organisms, including stem cells. This review explores CRISPR/Cas applications in stem cell research for disease understanding and novel therapeutic strategies.

Keywords:
Clustered regularly interspaced short palindromic repeatsGenome editingStem cellTranscriptional regulator

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.0K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K

Related Experiment Videos

Last Updated: Jul 12, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
09:04

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

8.3K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.0K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K

Area of Science:

  • Genomics
  • Molecular Biology
  • Stem Cell Research

Background:

  • The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system is a powerful genome editing technology.
  • CRISPR allows for precise DNA modifications, including single nucleotide conversions, gene knock-ins, chromosomal rearrangements, and gene disruptions.
  • CRISPR-based epigenetic regulation can be achieved without inducing DNA damage.

Purpose of the Study:

  • To review the latest advancements in stem cell research utilizing CRISPR/Cas technologies.
  • To discuss the potential of CRISPR-mediated stem cell engineering in understanding disease pathogenesis.
  • To explore future prospects of CRISPR applications in treating incurable diseases.

Main Methods:

  • Review of current CRISPR/Cas technologies applied to stem cell research.
  • Analysis of gene editing capabilities for precise DNA alterations.
  • Examination of epigenetic regulation strategies using CRISPR systems.

Main Results:

  • CRISPR technology facilitates diverse and precise genome editing in stem cells.
  • CRISPR applications offer insights into disease mechanisms and potential therapeutic targets.
  • CRISPR-Cas systems are being explored for epigenetic modifications in stem cells.

Conclusions:

  • CRISPR/Cas technologies hold significant promise for stem cell engineering.
  • Stem cell gene editing is crucial for advancing disease research and developing treatments.
  • Future applications of CRISPR in stem cell therapy are extensive for various diseases.